Ortho Clinical Diagnostics Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 BIO New Uptrend Bullish
2021-04-16 BIO Upper Bollinger Band Walk Strength
2021-04-16 BIO Pocket Pivot Bullish Swing Setup
2021-04-16 CEMI NR7 Range Contraction
2021-04-16 CEMI Narrow Range Bar Range Contraction
2021-04-16 CEMI Death Cross Bearish
2021-04-16 CODX Hammer Candlestick Bullish
2021-04-16 CODX NR7 Range Contraction
2021-04-16 CODX Narrow Range Bar Range Contraction
2021-04-16 CODX Lizard Bullish Bullish Day Trade Setup
2021-04-16 OCDX 50 DMA Support Bullish
2021-04-16 TMO Upper Bollinger Band Walk Strength

Recent News for Ortho Clinical Diagnostics Stocks

Date Stock Title
Apr 16 BIO Bio-Rad: Sartorius Portfolio Inclusion The Key Differentiator
Apr 16 TMO SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PPD, Inc. Buyout
Apr 16 TMO Jaguar Holding Company II, LLC -- Moody's places PPD's ratings under review for upgrade on proposed acquisition by Thermo Fisher
Apr 16 TMO PPD cut following Thermo Scientific deal, Apellis and Iovance initiated as buys, and more in today's analyst action
Apr 16 TMO 5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD
Apr 16 TMO Company News for Apr 16, 2021
Apr 16 TMO PPD, Inc. (PPD) Soars 6.5%: Is Further Upside Left in the Stock?
Apr 16 TMO What's in Store for Intuitive Surgical's (ISRG) Q1 Earnings?
Apr 15 TMO SHAREHOLDER ALERT: WeissLaw LLP Investigates PPD, Inc.
Apr 15 TMO Icon wins U.S. antitrust approval for PRA Health acquisition
Apr 15 TMO Thermo Fisher marks efficient capital deployment with PPD deal
Apr 15 TMO Thermo Fisher Scientific (Finance I) B.V. -- Moody's affirms Thermo Fisher Scientific's Baa1 senior unsecured rating; outlook stable
Apr 15 TMO Thermo Fisher Bets Big on Clinical Research With a $17.4 Billion Deal
Apr 15 TMO PPD ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PPD and Encourages Investors to Contact the Firm
Apr 15 TMO Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today
Apr 15 TMO Thermo Expands Its Biggest Business With $17.4 Billion PPD Buyout
Apr 15 TMO Syneos Health gains following Thermo Fisher $17B deal for PPD
Apr 15 TMO Thermo to Buy PPD for $17.4 Billion as Health Deals Soar
Apr 15 BIO.B Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
Apr 15 BIO Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
Related Industries: Diagnostics & Research

Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing. Ortho serves two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood.
Johnson and Johnson acquired Eastman Kodak's Clinical Diagnostics Division in 1994 (to form Johnson & Johnson Clinical Diagnostics), which was then merged with Ortho Diagnostic Systems in 1997. Ortho's global corporate offices are in Raritan, New Jersey, while their global research and development center is in Rochester, New York.
In 2014, The Carlyle Group purchased the company from Johnson & Johnson for $4.15 billion. Ortho Clinical Diagnostics now operates as an independent company.Ortho Clinical Diagnostics (Ortho) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson. In his first act as Ortho's Chairman and CEO, Dr. Martin D. Madaus announced key appointments in finance, operations, legal and commercial to advance strategic sectors of the In Vitro Diagnostics (IVD) business.

More about Ortho Clinical Diagnostics
Browse All Tags